dimethandrolone undecanoate
Small moleculeexperimental
Dimethandrolone undecanoate (DMAU), also known by its developmental code name CDB-4521, is an experimental androgen/anabolic steroid (AAS) and progestogen medication which is under development as a potential birth control pill for men. It is taken by mouth, but can also be given by injection into muscle. — Wikipedia
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2012 (NCT01382069)
Timeline
Indications
Mechanism of action
- Estrogen receptor alphaDISRUPTING AGENT
ESR1 disrupting agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaDimethandrolone undecanoate ↗
Also known as
- dimethandrolone undecanoate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03455075 | Phase 2 | Apr 16, 2018 | Health Decisions, Los Angeles Biomedical Research Institute, National Institutes of Health (NIH), University of Washington |
| NCT02927210 | Phase 1 | Dec 1, 2016 | Health Decisions, Los Angeles Biomedical Research Institute, National Institutes of Health (NIH), University of Washington |
| NCT01382069 | Phase 1 | Mar 1, 2012 | Los Angeles Biomedical Research Institute, National Institutes of Health (NIH), University of Washington |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Los Angeles Biomedical Research Institute | Academic/Hospital | 3 | 1 | 2 | 2012 |
| National Institutes of Health (NIH) | Government | 3 | 0 | 2 | 2012 |
| University of Washington | Academic/Hospital | 3 | 0 | 2 | 2012 |
| Health Decisions | For profit | 2 | 2 | 2 | 2016 |
4 organizations
Page 1 / 1